Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Learn the telltale signs you should revise your budget, including income changes, expense spikes, and shifting priorities.
24,979 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
XRP trades around $1.15 as Ripple builds regulatory momentum and broader adoption. Investors ask if the price underpl...
A federal appeals court blocked the CFPB’s plan to lay off most of its staff, sending the dispute back to a district ...
Two Harbors moved its special meeting to July 2 to push the CrossCountry Mortgage deal through, while a rival bid fro...
World Cup 2026 in the U.S. has sparked a spending spree among fans who travel with dreams of the tournament, even if ...
IBM unveils a groundbreaking 0.7nm nanostack in a research setting, reiterating it will not become a chipmaker. The m...
NOWPayments and KoinX launch Crypto Tax Educational Assets to help global merchants navigate crypto tax rules as cros...
HYPE and XRP ETFs drew record inflows even as SOL and BTC funds faced net losses, signaling a split in crypto ETF dem...
Florida Gov. Ron DeSantis signed Live Local 4.0, marking a decisive shift in housing policy. The measure preempts loc...
Marvell Technology extended a dramatic rally, up 45% in a month on record revenue, while investors weigh whether to t...
A fresh AI hardware rally lifts Super Micro Computer while Meta Platforms remains the core beneficiary of AI spend, e...
Analysts convene Thursday to highlight key stock moves ahead of a holiday weekend, with fresh targets and cautions ac...